<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04198454</url>
  </required_header>
  <id_info>
    <org_study_id>STU00211239</org_study_id>
    <nct_id>NCT04198454</nct_id>
  </id_info>
  <brief_title>Compression and CO2 Laser for Leg Wounds</brief_title>
  <official_title>Randomized, Investigator-blinded Study of Compression in Wound Healing With and Without Fractional Ablative CO2 Laser After Excisions on the Lower Extremity (CHIME+)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy and safety of compression bandaging&#xD;
      with fractional ablative carbon dioxide laser (FACL) compared to compression and standard&#xD;
      dressings alone for healing of post-operative wounds of the leg.&#xD;
&#xD;
      This is a randomized, SMART design, clinical trial. Approximately 80 participants will be&#xD;
      randomized to initially receive compression bandages or standard wound dressings after&#xD;
      surgery on the lower leg. After 4 weeks, the group assigned to compression bandages will be&#xD;
      further randomized to either continue with the compression bandages only or continue with the&#xD;
      compression bandages and also receive (FACL). The study is designed as an 6-month study. This&#xD;
      study was a pilot study designed to determine feasibility of these procedure.&#xD;
&#xD;
      Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion&#xD;
      criteria will be considered for enrollment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">February 17, 2020</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Sequential, multiple assignment, randomized trials (SMARTs)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean change wound size as determined by measurements</measure>
    <time_frame>Baseline to 6 months</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Wound Healing</condition>
  <arm_group>
    <arm_group_label>Compression bandages</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Class I (20-30 mmHg) compression bandages or stocking. This is considered a standard measure in the recovery of lower extremity wounds and often recommended.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard wound dressings</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Wound dressings alone consisting of gauze and skin tape to cover the wound.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Compression bandages with FACL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Class I compression (20-30 mmHg) bandage or stocking with FACL.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Compression bandages</intervention_name>
    <description>Class I (20-30 mmHg) compression bandages or stocking</description>
    <arm_group_label>Compression bandages</arm_group_label>
    <arm_group_label>Compression bandages with FACL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard wound dressings</intervention_name>
    <description>Wound dressings alone consisting of gauze and skin tape to cover the wound</description>
    <arm_group_label>Standard wound dressings</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fractional ablative carbon dioxide laser</intervention_name>
    <description>Participant will have laser applied to their wound bed.</description>
    <arm_group_label>Compression bandages with FACL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:Patients will be identified through the clinic where their skin is to be&#xD;
        treated by excisional surgery on the lower leg. Those considered for enrollment must also&#xD;
        meet the following criteria:&#xD;
&#xD;
          1. &gt;18 years of age&#xD;
&#xD;
          2. Wound size of at least 1 cm in width&#xD;
&#xD;
          3. Cutaneous excision of the lower leg&#xD;
&#xD;
          4. Surgeon elected repair of healing by secondary intention&#xD;
&#xD;
          5. Participants must have the ability to understand and the willingness to sign a written&#xD;
             informed consent prior to registration on study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Current smoker&#xD;
&#xD;
          2. Uncontrolled diabetes mellitus&#xD;
&#xD;
          3. Uncontrolled hypothyroidism&#xD;
&#xD;
          4. Severe renal impairment or hypoalbuminemia&#xD;
&#xD;
          5. Chronic lymphedema&#xD;
&#xD;
          6. Severe venous insufficiency (large varicose veins, atrophie blanche)&#xD;
&#xD;
          7. Arterial insufficiency (ABI &lt; 0.8)&#xD;
&#xD;
          8. Rubber or rubber accelerator allergy&#xD;
&#xD;
          9. Prior radiation to the surgical site&#xD;
&#xD;
         10. History or evidence of a clinically significant medical or psychiatric disorder,&#xD;
             condition or disease that in the opinion of the treating physician would pose a risk&#xD;
             or interfere with evaluation or completion of the study&#xD;
&#xD;
         11. Subject un willing to sign an IRB approved consent form&#xD;
&#xD;
         12. Participants who are unable to communicate or cooperate with the investigator due to&#xD;
             language problems, poor mental development, or impaired cerebral function are not&#xD;
             eligible&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Murad Alam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University Department of Dermatology</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>December 12, 2019</study_first_submitted>
  <study_first_submitted_qc>December 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2019</study_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Murad Alam</investigator_full_name>
    <investigator_title>Professor of Dermatology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

